International Journal of Biological Macromolecules Cover Letter: What Editors Actually Need to See

A useful letter can be tested as four connected sentences. Each sentence should add evidence rather than repeat the abstract.

Read those four sentences without the rest of the letter. If they do not form one causal chain, the submission case is not yet clear enough.

The International Journal of Biological Macromolecules cover letters that work establish a genuine macromolecule contribution: they state what is new about the polysaccharide, protein, or biopolymer work and why the characterization supports the claims, rather than presenting routine extraction or testing. The ones that fail leave the contribution and the macromolecule focus implicit. Lead with the specific advance and rigorous characterization, and confirm scope-fit, since that is what the editors screen for.

Elsevier's Guide for Authors lists the scope: proteins, polysaccharides, nucleic acids, lignin, chitosan, cellulose, and other biologically derived polymers. It describes manuscript types, formatting requirements, and the Editorial Manager submission workflow. What it does not spell out is how strictly the editors enforce macromolecule centrality at the desk-rejection stage.

The current journal page names Yangchao Luo and Yue Zhang among the Executive Editors and lists an optional open-access APC of USD 4,170, excluding taxes; the subscription route lists no author publication fee. Submit through the journal's Editorial Manager portal. Treat the fee and editor list as volatile facts and recheck them on the official journal page before upload.

The distinction trips up a large number of authors. If you used chitosan nanoparticles for drug delivery but your paper is really about pharmacokinetics, IJBM will not publish it. If you characterized how the chitosan's molecular weight and degree of deacetylation affect nanoparticle formation, it fits. The cover letter must make that distinction obvious in the first two sentences.

IJBM uses academic editors who are active macromolecule researchers. They will recognize immediately whether your paper investigates the macromolecule or merely uses one. Vague phrasing about "novel biopolymer composites" will not survive if the manuscript is really a standard application study.

At triage, the editor is usually asking:

• Is the biological macromolecule the focus of the research, or is it incidental to an application?

• Does the paper include structural or physicochemical characterization (FTIR, XRD, TGA, CD, rheology, NMR)?

• Does the work advance understanding of how the macromolecule behaves, not just report a routine preparation?

• Is IJBM the right journal, or would Carbohydrate Polymers or Biomacromolecules be a better fit?

A cover letter that answers the first question in the opening paragraph will survive triage.

• Writing an application paper (drug delivery, wound healing) and framing it as macromolecule research without characterizing the macromolecule itself

• Not mentioning any characterization techniques, which signals to the editor that structural work may be missing entirely

• Using a generic novelty claim such as "first study to investigate" instead of positioning your findings against the closest prior work

• Submitting to IJBM when the work is exclusively about a polysaccharide that fits better in Carbohydrate Polymers

• Burying the macromolecule name deep in the letter instead of leading with it in the first sentence

Before refining the cover letter, ask whether the macromolecule is genuinely the subject of the research or just a material you used. If removing the macromolecule name would not change the paper's contribution, the manuscript belongs elsewhere. Review the IJBM Guide for Authors and confirm the macromolecular investigation runs through the entire study.

IJBM editors eliminate papers where the macromolecule is a tool rather than the research subject. The cover letter's job is to prove yours is an exception.

So the useful takeaway is this: name the macromolecule, state the structural or functional property you studied, and report a specific finding in the opening paragraph. A IJBM cover letter framing check is a direct way to pressure-test whether your framing already does that before submission.

For manuscripts targeting International Journal of Biological Macromolecules, the main cover-letter failure is that authors often treat the biopolymer as the material they used rather than the scientific subject they studied. IJBM editors usually spot that distinction immediately.

The first recurring failure is application-led framing with no macromolecular question. A wound dressing, delivery system, film, or scaffold may use chitosan, cellulose, starch, gelatin, or protein materials, but if the letter never explains what was learned about the macromolecule itself, the manuscript reads like an application paper for another journal.

The second failure is not surfacing the characterization story early enough. IJBM editors expect structural or physicochemical evidence, not just performance claims. When the cover letter does not mention the methods that establish macromolecular behavior, the paper looks mechanically thin even if the data are in the manuscript.

The third failure is ignoring the boundary with Carbohydrate Polymers and Biomacromolecules. If the paper is entirely polysaccharide-focused, the letter should still explain why IJBM is the right venue. If the macromolecule is only a carrier in a delivery or biomedical system, the editor will often see a scope mismatch immediately.

A IJBM cover letter framing check is a direct way to test whether the manuscript genuinely reads macromolecule-first before submission.

Keep the letter concise, but do not make it generic. Editors are usually screening for macromolecule centrality, the structural or physicochemical evidence behind the claim, and whether the journal fit is stronger than adjacent biopolymer or application venues.

A IJBM cover letter and desk-rejection risk check scores fit against the journal's editorial bar.

The cover letter should survive a simple deletion test: remove the biomolecule name and ask whether the same pitch could describe a generic material, coating, or delivery system. If it can, the journal-fit argument is too weak.

This decision artifact turns “biomacromolecular relevance” into claims an editor can check.

Read the title, first figure, and main conclusion while replacing the named macromolecule with the phrase “functional material.” If the argument still works, the biological macromolecule may be incidental rather than the paper's scientific center. A stronger IJBM case explains how macromolecular structure, interaction, conformation, assembly, or biological function creates the observed consequence.

Then trace that explanation into a discriminating experiment. A performance increase alone rarely distinguishes the proposed mechanism from plausible alternatives. The letter should point to the control, structural evidence, perturbation, or comparison that makes the macromolecular interpretation credible. End with the boundary: the system, scale, organism, processing condition, or model that the evidence has not yet crossed.

Official and authoritative sources accessed 2026-08-17.

1. IJBM Guide for Authors

1. IJBM Aims and Scope

1. IJBM Editorial Board

1. Elsevier Editorial Process